IT Inhibitor Therapeutics, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Inhibitor Therapeutics, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €15.4m. The latest transaction was disclosed on 4 August 2026 (Don). Among the most active insiders: Yanez Michelle. The full history is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 August 2026
All Executives18 Thresholds0 Prospectus0 Other0
Declarations 18 total
● 10% Owner · Executives · 1 Jul 2026
3,200,000 shares 0Common Stock SEC:0001493152-26-036080:0
◆ Chief Executive Officer · Executives · 4 May 2026
50,000 shares 0Common Stock SEC:0001493152-26-035950:0
◆ Director · Executives · 4 May 2026
50,000 shares 0Common Stock SEC:0001493152-26-035953:0
◆ Director · Executives · 4 May 2026
50,000 shares 0Common Stock SEC:0001493152-26-035955:0
◆ Director · Executives · 4 May 2026
50,000 shares 0Common Stock SEC:0001493152-26-035962:0
◆ Director · Executives · 4 May 2026
50,000 shares 0Common Stock SEC:0001493152-26-029898:0
◆ Director · Executives · 1 Apr 2025
50,000 shares 0Common Stock SEC:0001641172-25-003556:0
◆ Director · Executives · 1 Apr 2025
50,000 shares 0Common Stock SEC:0001641172-25-003033:0
◆ Director · Executives · 1 Apr 2025
50,000 shares 0Common Stock SEC:0001641172-25-003025:0
◆ Director · Executives · 1 Apr 2025
50,000 shares 0Common Stock SEC:0001641172-25-003023:0
◆ Director · Executives · 1 Apr 2025
50,000 shares 0Common Stock SEC:0001641172-25-003029:0
◆ Director · Executives · 1 Apr 2024
50,000 shares 0Common Stock SEC:0001493152-24-020173:0
◆ Director · Executives · 1 Apr 2024
50,000 shares 0Common Stock SEC:0001493152-24-020171:0
◆ Director · Executives · 1 Apr 2024
50,000 shares 0Common Stock SEC:0001493152-24-020172:0
◆ Director · Executives · 1 Apr 2024
50,000 shares 0Common Stock SEC:0001493152-24-020170:0
◆ Director · Executives · 11 Aug 2023
25,000 shares 0Common Stock SEC:0000950170-23-045043:0
● Director · Executives · 5 May 2023
796,271 shares 0Common Stock SEC:0000899243-23-013195:0
● See Remarks · Executives · 5 May 2023
79,627,069 shares 0Common Stock SEC:0000899243-23-013201:0
Acerca de Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc. es una empresa centrada en el desarrollo de terapias innovadoras para enfermedades graves. Cotiza en el mercado XNAS.